AGTR1 and endothelial dysfunction: Moreover, treatment of rats with either an angiotensin-converting enzyme inhibitor or an AT1 receptor antagonist effectively ameliorated endothelial dysfunction, both the NO component and the EDHF component, in aged blood vessels, in part, by decreasing vascular oxidative stress [7], [9], [10], [44].